Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
2008-08-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Suprascapular Nerve Block and Subacromial Injection in Hemiplegic Shoulder Pain
NCT04433377
Suprascapular Nerve Block Versus Intraarticular Steroid Injection in Hemiplegic Shoulder Pain
NCT04128605
Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients
NCT05260125
Evaluation of the Effectiveness of Pericapsular Nerve Group Block in Hemiplegic Shoulder Pain
NCT07302711
Ultrasound-guided Selective Shoulder Block Versus Ultrasound-guided Interscalene Brachial Plexus Block, an RCT
NCT02415088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Suprascapular nerve block
1% xylocaine
10 cc. of 1%xylocaine, once a week
B
therapeutic ultrasound
ultrasound
ultrasound at shoulder area about 10 mins.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1% xylocaine
10 cc. of 1%xylocaine, once a week
ultrasound
ultrasound at shoulder area about 10 mins.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good conscious and able to access pain score.
* No history of drug reaction with xylocaine
* No history of fracture,tumor or blood tendency.
* Willing to enrolled to study and signs inform consent.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chulalongkorn University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jariya Boonhong, physiatist
Role: PRINCIPAL_INVESTIGATOR
Unaffiliation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of physical medicine and rehabilitation, Faculty of medicien, Chulalongkorn University
Bangkok, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Chulalongkorn University
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.